Akebia Therapeutics Inc (FRA:AX9)
€ 1.642 0.149 (9.98%) Market Cap: 359.71 Mil Enterprise Value: 368.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q3 2023 Akebia Therapeutics Inc Earnings Call Transcript

Nov 08, 2023 / 01:00PM GMT
Release Date Price: €1.02 (+11.14%)
Operator

Good day, and thank you for standing by. Welcome to the Akebia Therapeutics Third Quarter 2023 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. And I would now like to hand the conference over to your speaker today, Ms. Mercedes Carrasco. Please go ahead.

Mercedes Carrasco
Akebia Therapeutics, Inc. - Director of Corporate Communications

Thank you. Thank you, and welcome to Akebia's Third Quarter 2023 Financial Results and Business Update Conference Call. Please note that a press release was issued earlier today, Wednesday, November 8, detailing our third quarter financial results, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will also be available on our website after we conclude.

Joining me for today's call, we have John Butler, Chief Executive Officer; and Ellen Snow, Chief Financial Officer.

I'd like to remind everyone that this call includes forward-looking statements. Each forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot